TOP MS is a Study of Multiple Sclerosis Disease Management in Collaboration With Specialty Pharmacies.
Phase of Trial: Phase IV
Latest Information Update: 28 Jan 2013
At a glance
- Drugs Glatiramer acetate (Primary) ; Interferon beta-1a; Interferon beta-1a; Interferon beta-1b
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms TOP-MS
- Sponsors Teva Neuroscience
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Oct 2012 Results were presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in October 2012.
- 14 Oct 2011 Results will be presented at the 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS and ACTRIMS), according to a Teva Pharmaceutical Industries media release.